In conclusion, we have evaluated the potential of AFP, AFP-L3, GP73, and DCP serum biomarkers for HCC diagnosis, and developed diagnostic models using these biomarkers and MLP and RBF neural networks to differentiate HCC and early stage HCC from LC patients. Here, AFP is linked to laryngotracheoesophageal cleft.